Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P (TARGET3D)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02634008

Recruitment Status : Recruiting

First Posted : December 17, 2015

Last Update Posted : June 25, 2021

See Contacts and Locations

Sponsor:

Collaborator:

AbbVie

Information provided by (Responsible Party):

Kirby Institute

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Recruiting
Actual Primary Completion Date :	April 30, 2021
Estimated Study Completion Date :	December 2024

To Top